PlainPill

Gabapentin

Also known as Neurontin

The short answer. Most people who report on Gabapentin say it did not help (only 39% of 81 positive). It is most often used for anxiety: 80% of 44 reports say that improved. It is well studied — 532 meta-analyses on PubMed. The most common complaint is withdrawal.

What users report
39%helped81 reports · medium confidence
32 helped28 mixed22 didn't help

From 145 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
532
meta-analyses
672
RCTs
8,910
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Gabapentin does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 532 meta-analyses on PubMed ↗ · 672 randomized trials ↗

Lancet Neurol · 2015 · Meta-analysis / systematic review
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Conclusion: Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain. Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain. Modest efficacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profiling probably account for moderate trial outcomes and should be taken into account in future studies.

PubMed 25575710 ↗
Menopause · 2024 · Meta-analysis / systematic review
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

Conclusion: The only HT regimens that showed significantly greater efficacy than fezolinetant 45 mg on any of the outcomes analyzed are not available in the United States. Fezolinetant 45 mg once daily was statistically significantly more effective than other non-HTs in reducing the frequency of moderate to severe VMS.

PubMed 38016166 ↗
Registered clinical trials

581 human trials on ClinicalTrials.gov test Gabapentin — 369 completed, 37 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

Not a scheduled substance, but the DEA lists Gabapentin as a drug of concern. DEA fact sheet ↗

FDA drug label

The current US prescription label has no boxed warning.

Full label on DailyMed (NIH) ↗

FDA recalls

24 recalls of products named for Gabapentin. Most recent:

  • 2025-10-29 · Class II: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . record ↗
  • 2025-07-09 · Class II: Defective container; blister packaging inadequately sealed. record ↗
  • 2025-04-16 · Class II: CGMP Deviations record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

362,654 adverse-event reports mention Gabapentin. Most often reported:

  • Drug ineffective · 29,635
  • Fatigue · 25,140
  • Nausea · 22,785
  • Pain · 21,256
  • Off label use · 19,830
  • Diarrhoea · 18,156

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Gabapentin C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 45 research projects with Gabapentin in the title, $34,709,226 in total (1988–2026). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Gabapentin ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

withdrawal ×8cognitive impairment ×5brain fog ×5addiction ×4tolerance ×3dependence ×3drowsiness ×3memory issues ×2

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I took Gabapentin today and I'm feeling calm like I used to... After 3 years I can finally feel normal... stomach issues disappeared and my sleep improved.”
HelpedRead the discussion ↗
“I’m prescribed gabapentin for anxiety but it stopped working. I was using it every other day for a long time and doing pretty good but then my sleep got all messed up.”
MixedRead the discussion ↗
“I found that Neurontin is absolutely amazing for anxiety, social interaction and uplifting mood.”
HelpedRead the discussion ↗
“I'm about +5 hours after my 2g dose... I feel very upbeat... A functioning, mood-enhanced, relaxation with undertones of stimulation.”
HelpedRead the discussion ↗
Read more Gabapentin reviews →
Top discussions (5)

Gabapentin compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate